Literature DB >> 240819

Diminished 5alpha-reductase activity in extracts of fibroblasts cultured from patients with familial incomplete male pseudohermaphroditism, type 2.

R J Moore, J E Griffin, J D Wilson.   

Abstract

The activity of 5alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone, has been assessed in cell-free extracts of fibroblasts grown from foreskin, labia majora, scrotum, and nongenital skin from control subjects, from patients with developmental defects of the urogenital system, drom two subjects with the type 2 form of familial incomplete male pseudohermaphroditism and from individuals with other forms of hereditary male pseudohermaphoditism. Enzyme activity was shown to be maximal in the pH range of 5 to 6. Substrate specificity studies indicated that the enzyme so assayed is the 5alpha-reductase previously characterized in human foreskin. The activity of the enzyme was low in normal fibroblasts grown from nongenital skin and high in most fibroblasts grown from genital skin. 5alpha-Reductase activity in extracts of foreskin fibroblasts from two subjects with the type 2 disorder was undetectable at pH 5.5. Activity in comparable fibroblast extracts from most patients with other forms of hereditary male pseudohermaphroditism was easily measurable.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 240819

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Pituitary-gonadal axis in male undermasculinisation.

Authors:  K L Ng; S F Ahmed; I A Hughes
Journal:  Arch Dis Child       Date:  2000-01       Impact factor: 3.791

Review 2.  Use of 5alpha-reductase inhibitors to prevent benign prostatic hyperplasia disease.

Authors:  Leonard S Marks
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

3.  Hereditary male pseudohermaphroditism associated with an unstable form of 5 alpha-reductase.

Authors:  M Leshin; J E Griffin; J D Wilson
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

4.  Dihydrotestosterone binding by cultured human fibroblasts. Comparison of cells from control subjects and from patients with hereditary male pseudohermaphroditism due to androgen resistance.

Authors:  J E Griffin; K Punyashthiti; J D Wilson
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

5.  Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases.

Authors:  S Andersson; D W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor.

Authors:  P Price; J A Wass; J E Griffin; M Leshin; M O Savage; D M Large; D E Bu'Lock; D C Anderson; J D Wilson; G M Besser
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

7.  Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism.

Authors:  S Andersson; D M Berman; E P Jenkins; D W Russell
Journal:  Nature       Date:  1991-11-14       Impact factor: 49.962

8.  5α-Reductase Isozymes in the Prostate.

Authors:  Yuan-Shan Zhu; Guang-Huan Sun
Journal:  J Med Sci       Date:  2005

9.  Male pseudohermaphroditism due to primary 5 alpha-reductase deficiency: variation in gender identity reversal in seven Mexican patients from five different pedigrees.

Authors:  J P Méndez; A Ulloa-Aguirre; J Imperato-McGinley; A Brugmann; M Delfin; B Chávez; C Shackleton; S Kofman-Alfaro; G Pérez-Palacios
Journal:  J Endocrinol Invest       Date:  1995-03       Impact factor: 4.256

10.  Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase.

Authors:  E P Jenkins; S Andersson; J Imperato-McGinley; J D Wilson; D W Russell
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.